Viromed Medical AG (ETR:VME)
Germany · Delayed Price · Currency is EUR 7.70
-0.05 (-0.65%)
At close: Aug 5, 2026
Viromed Medical AG Revenue
In the year 2025, Viromed Medical AG had annual revenue of 5.09M EUR with 352.27% growth. Viromed Medical AG had revenue of 2.67M in the half year ending December 31, 2025.
Revenue
5.09M
Revenue Growth
+352.27%
P/S Ratio
32.16
Revenue / Employee
299.24K
Employees
17
Market Cap
163.63M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.09M | 3.96M | 352.27% |
| Dec 31, 2024 | 1.12M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.24B |
| Siemens Healthineers AG | 23.17B |
| Fresenius SE & Co. KGaA | 22.99B |
| Merck KGaA | 20.96B |
| Medios AG | 2.12B |
| MEDICLIN Aktiengesellschaft | 819.84M |
| M1 Kliniken AG | 364.30M |
| Stratec SE | 243.93M |